| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.18B | 5.24B | 6.40B | 6.81B | 5.85B | 4.35B |
| Gross Profit | 1.28B | 1.35B | 1.79B | 1.95B | 1.67B | 1.21B |
| EBITDA | 163.80M | 618.70M | 1.01B | 1.18B | 980.40M | 693.40M |
| Net Income | -238.50M | 130.10M | 420.40M | 677.00M | 593.30M | 372.70M |
Balance Sheet | ||||||
| Total Assets | 5.41B | 5.68B | 6.23B | 6.32B | 5.42B | 3.77B |
| Cash, Cash Equivalents and Short-Term Investments | 298.50M | 269.80M | 468.60M | 600.10M | 355.30M | 576.30M |
| Total Debt | 2.34B | 2.51B | 2.59B | 2.63B | 1.92B | 1.04B |
| Total Liabilities | 3.78B | 3.79B | 4.14B | 4.28B | 3.51B | 2.26B |
| Stockholders Equity | 1.63B | 1.89B | 2.09B | 2.04B | 1.91B | 1.51B |
Cash Flow | ||||||
| Free Cash Flow | 588.80M | 264.00M | 444.30M | 197.80M | 306.90M | 615.90M |
| Operating Cash Flow | 735.60M | 431.40M | 733.60M | 586.10M | 574.00M | 798.30M |
| Investing Cash Flow | -112.40M | -168.90M | -378.90M | -443.20M | -1.35B | -246.90M |
| Financing Cash Flow | -608.90M | -442.70M | -487.00M | 110.80M | 621.80M | -361.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $2.77B | 16.01 | 12.89% | 4.01% | 5.74% | 39.40% | |
71 Outperform | $295.15M | 28.73 | 7.40% | ― | -12.17% | ― | |
65 Neutral | $524.31M | 27.75 | 3.72% | ― | 11.54% | ― | |
64 Neutral | $304.84M | 23.44 | 10.00% | 6.43% | -12.30% | -29.51% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
52 Neutral | $4.55B | ― | -12.31% | 2.46% | -4.78% | -189.89% | |
50 Neutral | $250.30M | -18.86 | -35.49% | ― | 5.62% | -1706.59% |
On November 26, 2025, Brunswick Corporation announced the early tender results for its tender offer to purchase $300 million of its 5.100% Senior Notes due 2052. The company increased the tender cap from $50 million to $100 million, and by the early tender deadline, $111 million of notes were tendered. Due to oversubscription, Brunswick will only accept $100 million worth of notes, applying a proration rate of 90.2%. The settlement is expected on December 1, 2025, and no further notes will be accepted after the early tender deadline.
On November 12, 2025, Brunswick Corporation announced the commencement of a tender offer to purchase up to $50 million of its outstanding $300 million 5.100% Senior Notes due 2052. This move is part of Brunswick’s financial strategy to manage its long-term debt obligations, potentially impacting its financial flexibility and market positioning. The tender offer is set to expire on December 11, 2025, with specific conditions and deadlines for noteholders to consider.
On October 31, 2025, Brunswick Corporation announced the full redemption of its 6.500% Senior Notes due 2048 and a partial redemption of its 6.375% Senior Notes due 2049, both set for December 1, 2025. This financial maneuver will result in the redemption of $185 million of the 2048 Notes and $15 million of the 2049 Notes, with an aggregate redemption price of $201.7 million, leaving no 2048 Notes and $215 million of 2049 Notes outstanding.